{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:11:30Z","timestamp":1780333890000,"version":"3.54.1"},"reference-count":190,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1002\/smrj.49","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T10:57:37Z","timestamp":1430305057000},"page":"183-202","source":"Crossref","is-referenced-by-count":23,"title":["Current and Emerging Treatments for Premature Ejaculation"],"prefix":"10.1093","volume":"3","author":[{"given":"Chris G.","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1002\/smrj.49_bb0010","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jsm.12504","article-title":"An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE)","volume":"11","author":"Althof","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1743-6109.2004.10109.x","article-title":"Disorders of orgasm and ejaculation in men","volume":"1","author":"McMahon","year":"2004","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10532528.2006.10559839","article-title":"Sexual therapy in the age of pharmacotherapy","volume":"17","author":"Althof","year":"2006","journal-title":"Annu Rev Sex Res"},{"key":"10.1002\/smrj.49_bb0025","series-title":"Principles and practice of sex therapy (4th Edition)","first-page":"212","article-title":"Treatment of rapid ejaculation: Psychotherapy, pharmacotherapy, and combined therapy","author":"Althof","year":"2007"},{"key":"10.1002\/smrj.49_bb0030","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1038\/sj.ijir.3901075","article-title":"Sex coaching for physicians: Combination treatment for patient and partner","volume":"15","author":"Perelman","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0035","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1743-6109.2006.00238.x","article-title":"A new combination treatment for premature ejaculation. A sex therapist's perspective","volume":"3","author":"Perelman","year":"2006","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0040","series-title":"PE: How to overcome premature ejaculation","author":"Kaplan","year":"1989"},{"key":"10.1002\/smrj.49_bb0045","series-title":"The evaluation of sexual disorders: The urologic evaluation of ejaculatory disorders","author":"Kaplan","year":"1983"},{"key":"10.1002\/smrj.49_bb0050","series-title":"Sexual life: A clinician's guide","first-page":"90","article-title":"Helping men to control ejaculation","author":"Levine","year":"1992"},{"key":"10.1002\/smrj.49_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/00926230500442292","article-title":"Effects of a new functional-sexological treatment for premature ejaculation","volume":"32","author":"de Carufel","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"10.1002\/smrj.49_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF01541925","article-title":"Group vs. couple treatment of sexual dysfunctions","volume":"7","author":"Golden","year":"1978","journal-title":"Arch Sex Behav"},{"key":"10.1002\/smrj.49_bb0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0005-7967(86)90062-8","article-title":"Long-term outcome of sex therapy","volume":"24","author":"Hawton","year":"1986","journal-title":"Behav Res Ther"},{"key":"10.1002\/smrj.49_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00926238408405949","article-title":"Three-year follow-up of couples evaluated for sexual dysfunction","volume":"10","author":"De Amicis","year":"1984","journal-title":"J Sex Marital Ther"},{"key":"10.1002\/smrj.49_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/ENDO:23:2-3:131","article-title":"Psychotherapy for erectile dysfunction: Now more relevant than ever","volume":"23","author":"Althof","year":"2004","journal-title":"Endocrine"},{"key":"10.1002\/smrj.49_bb0080","series-title":"Handbook of clinical sexuality for mental health professionals","first-page":"359","article-title":"Therapeutic weaving: The integration of treatment techniques","author":"Althof","year":"2003"},{"key":"10.1002\/smrj.49_bb0085","series-title":"Sexual desire disorders","first-page":"243","article-title":"A systems perspective on sexual desire","author":"Verhulst","year":"1988"},{"key":"10.1002\/smrj.49_bb0090","series-title":"Sexual dysfunction: A guide for assessment and treatment","author":"Wincze","year":"1991"},{"key":"10.1002\/smrj.49_bb0095","first-page":"S19","article-title":"Long term results of treatment of premature ejaculation with selective serotonin re-uptake inhibitors","volume":"14","author":"McMahon","year":"2002","journal-title":"Int J Imp Res"},{"key":"10.1002\/smrj.49_bb0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.111.004952","article-title":"Pharmacology for the treatment of premature ejaculation","volume":"64","author":"Giuliano","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1002\/smrj.49_bb0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-5347(17)70462-4","article-title":"Premature ejaculation, a review of 1130 cases","volume":"50","author":"Schapiro","year":"1943","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1358\/dof.2004.029.12.865936","article-title":"Dapoxetine hydrochloride","volume":"29","author":"Sorbera","year":"2004","journal-title":"Drugs Future"},{"key":"10.1002\/smrj.49_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clpt.2003.11.123","article-title":"Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers","volume":"75","author":"Dresser","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/smrj.49_bb0120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0091270006291033","article-title":"Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: Impact of age and effects of a high-fat meal","volume":"46","author":"Dresser","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/smrj.49_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0091270005284850","article-title":"Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation","volume":"46","author":"Modi","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/smrj.49_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.ijir.3901420","article-title":"Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors","volume":"18","author":"Dresser","year":"2006","journal-title":"Int J Impot Res"},{"issue":"Suppl 1","key":"10.1002\/smrj.49_bb0135","first-page":"59","article-title":"Dapoxetine HCl for the treatment of premature ejaculation: A Phase II, randomised, double-blind, placebo controlled study","volume":"1","author":"Hellstrom","year":"2004","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(18)35046-8","article-title":"Dapoxetine for the treatment of men with premature ejaculation (PE): Dose-finding analysis","volume":"173","author":"Hellstrom","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: An integrated analysis of two double-blind, randomised controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/smrj.49_bb0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: Results from a placebo-controlled phase III trial","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0165","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/jsm.12236","article-title":"Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: Randomized, placebo-controlled, phase III study","volume":"10","author":"McMahon","year":"2013","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2013.08.018","article-title":"Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: The PAUSE Study","volume":"65","author":"Mirone","year":"2014","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0175","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1743-6109.2008.00901.x","article-title":"An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/sm2.27","article-title":"An evidence-based unified definition of lifelong and acquired premature ejaculation: Report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation","volume":"2","author":"Serefoglu","year":"2014","journal-title":"Sex Med"},{"key":"10.1002\/smrj.49_bb0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0190","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1743-6109.2010.01820.x","article-title":"Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: Integrated analyses of two phase 3 dapoxetine trials","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0195","series-title":"Evaluation of withdrawal effects with dapoxetine in the treatment of premature ejaculation (PE). Poster presented at SMSNA","author":"Levine","year":"2006"},{"key":"10.1002\/smrj.49_bb0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","article-title":"Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis","volume":"16","author":"Waldinger","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0205","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1185\/030079906X132415","article-title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: A meta-analysis of head-to-head trials","volume":"22","author":"Machado","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1002\/smrj.49_bb0210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00003495-200767040-00005","article-title":"Premature ejaculation: Definition and drug treatment","volume":"67","author":"Waldinger","year":"2007","journal-title":"Drugs"},{"key":"10.1002\/smrj.49_bb0215","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4088\/JCP.v69n0605","article-title":"Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: Findings from STEP-BD","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/smrj.49_bb0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/appi.ajp.160.4.790","article-title":"Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports","volume":"160","author":"Khan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1002\/smrj.49_bb0225","first-page":"255","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria","volume":"25","author":"Black","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1002\/smrj.49_bb0230","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","article-title":"Serotonin reuptake inhibitor withdrawal","volume":"16","author":"Coupland","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/smrj.49_bb0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004850-200015060-00003","article-title":"An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram","volume":"15","author":"Markowitz","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/smrj.49_bb0240","first-page":"402","article-title":"A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples","volume":"56","author":"Althof","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/smrj.49_bb0245","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001721-199711000-00006","article-title":"Effects of serotonin on platelet activation in whole blood","volume":"8","author":"Li","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1002\/smrj.49_bb0250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.v61n1109","article-title":"Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment","volume":"61","author":"Fava","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/smrj.49_bb0255","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.fertnstert.2009.04.039","article-title":"Adverse effect of paroxetine on sperm","volume":"94","author":"Tanrikut","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1002\/smrj.49_bb0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ijir.2012.12","article-title":"Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation","volume":"24","author":"Koyuncu","year":"2012","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0265","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0022-5347(05)68816-7","article-title":"Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies","volume":"161","author":"McMahon","year":"1999","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00926239908403982","article-title":"Clomipramine in the treatment of rapid (premature) ejaculation","volume":"25","author":"Strassberg","year":"1999","journal-title":"J Sex Marital Ther"},{"key":"10.1002\/smrj.49_bb0275","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0090-4295(99)00187-9","article-title":"Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation","volume":"54","author":"Kim","year":"1999","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0280","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2004.05.005","article-title":"On-demand treatment of premature ejaculation with clomipramine and paroxetine: A randomized, double-blind fixed-dose study with stopwatch assessment","volume":"46","author":"Waldinger","year":"2004","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0285","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0022-5347(05)68816-7","article-title":"Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies","volume":"161","author":"McMahon","year":"1999","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0290","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1111\/j.1743-6109.2009.01404.x","article-title":"Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation","volume":"6","author":"Salonia","year":"2009","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ijir.2014.37","article-title":"Antidepressant treatment of premature ejaculation: Discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting","volume":"27","author":"Jern","year":"2015","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0300","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.urology.2013.05.018","article-title":"Dapoxetine treatment in patients with lifelong premature ejaculation: The reasons of a \u201cWaterloo\u201d","volume":"82","author":"Mondaini","year":"2013","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0305","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4103\/1008-682X.128467","article-title":"Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation","volume":"16","author":"Simsek","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1002\/smrj.49_bb0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-4328(97)00183-6","article-title":"Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system","volume":"92","author":"Waldinger","year":"1998","journal-title":"Behav Brain Res"},{"key":"10.1002\/smrj.49_bb0315","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0022-5347(01)66861-7","article-title":"Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation","volume":"154","author":"Berkovitch","year":"1995","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3349\/ymj.1997.38.2.91","article-title":"Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: Preliminary clinical studies","volume":"38","author":"Xin","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1002\/smrj.49_bb0325","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","article-title":"Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study","volume":"93","author":"Busato","year":"2004","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1464-410X.2006.06583.x","article-title":"Topical eutectic mixture for premature ejaculation (TEMPE): A novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation","volume":"99","author":"Dinsmore","year":"2007","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/17425247.5.2.251","article-title":"TEMPE: Topical eutectic-like mixture for premature ejaculation","volume":"5","author":"Henry","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/smrj.49_bb0340","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1743-6109.2010.01913.x","article-title":"Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: Results of a phase III, double-blind, placebo-controlled study","volume":"7","author":"Carson","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0345","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0090-4295(99)00608-1","article-title":"Anesthetic block of the dorsal penile nerve inhibits vibratory-induced ejaculation in men with spinal cord injuries","volume":"55","author":"Wieder","year":"2000","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0350","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","article-title":"Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study","volume":"93","author":"Busato","year":"2004","journal-title":"Br J Urol Int"},{"key":"10.1002\/smrj.49_bb0355","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1464-410X.2009.08456.x","article-title":"PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double-blind, placebo-controlled study","volume":"103","author":"Dinsmore","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.ijir.3900630","article-title":"Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation","volume":"13","author":"Abdel-Hamid","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2605.2002.00368.x","article-title":"Management of premature ejaculation\u2014a comparison of treatment outcome in patients with and without erectile dysfunction","volume":"25","author":"Chia","year":"2002","journal-title":"Int J Androl"},{"key":"10.1002\/smrj.49_bb0370","first-page":"S33","article-title":"Premature ejaculation: Comparison of patroxetine alone, paroxetine plus local lidocaine and paroxetine plus sildenafil","volume":"14","author":"Erenpreiss","year":"2002","journal-title":"Int J Imp Res"},{"key":"10.1002\/smrj.49_bb0375","first-page":"S39","article-title":"Treatment of sildenfil as part of the treatment in premature ejaculation","volume":"14","author":"Linn","year":"2002","journal-title":"Int J Imp Res"},{"key":"10.1002\/smrj.49_bb0380","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ijir.3901063","article-title":"Premature ejaculation. Pharmacological treatment. Three years after","volume":"15","author":"Lozano","year":"2003","journal-title":"Int J Imp Res"},{"key":"10.1002\/smrj.49_bb0385","first-page":"366","article-title":"[Clinical efficacy of Viagra with behavior therapy against premature ejaculation]","volume":"10","author":"Tang","year":"2004","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-5347(18)35973-1","article-title":"Treatment of premature ejaculation: A comparative vardenafil and SSRI crossover study","volume":"173","author":"Sommer","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0395","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","article-title":"Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation","volume":"67","author":"Atan","year":"2006","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0400","first-page":"610","article-title":"[A clinical study of sertralin and vardenafil in the treatment of premature ejaculation complicated by erectile dysfunction]","volume":"13","author":"Sun","year":"2007","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0405","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"10.1002\/smrj.49_bb0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0415","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1439-0272.2008.00910.x","article-title":"Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study","volume":"41","author":"Mathers","year":"2009","journal-title":"Andrologia"},{"key":"10.1002\/smrj.49_bb0420","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1743-6109.2011.02401.x","article-title":"The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation","volume":"8","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0425","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0430","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0090-4295(03)00131-6","article-title":"Nitric oxide and the lower urinary tract: Current concepts, future prospects","volume":"61","author":"Mamas","year":"2003","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0435","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0440","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1743-6109.2011.02628.x","article-title":"Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis","volume":"9","author":"Asimakopoulos","year":"2012","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0445","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.eururo.2007.08.005","article-title":"The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data","volume":"52","author":"Chen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2490-5-18","article-title":"Indirect comparison of interventions using published randomised trials: Systematic review of PDE-5 inhibitors for erectile dysfunction","volume":"5","author":"Moore","year":"2005","journal-title":"BMC Urol"},{"key":"10.1002\/smrj.49_bb0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijir.3901250","article-title":"Sexual problems among women and men aged 40\u201380 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors","volume":"17","author":"Laumann","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0460","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.eururo.2004.07.001","article-title":"Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions","volume":"46","author":"Corona","year":"2004","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0465","first-page":"266","article-title":"[Clinical study of sildenafil in the treatment of premature ejaculation complicated by erectile dysfunction]","volume":"9","author":"Li","year":"2003","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0470","first-page":"520","article-title":"[Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation]","volume":"11","author":"Zhang","year":"2005","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0475","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-4295(02)02075-7","article-title":"Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0480","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000102909","article-title":"Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation","volume":"79","author":"Hosseini","year":"2007","journal-title":"Urol Int"},{"key":"10.1002\/smrj.49_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200464010-00002","article-title":"Phosphodiesterase 5 inhibitors in rapid ejaculation: Potential use and possible mechanisms of action","volume":"64","author":"Abdel-Hamid","year":"2004","journal-title":"Drugs"},{"key":"10.1002\/smrj.49_bb0495","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1111\/j.1743-6109.2010.02062.x","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"7","author":"Montorsi","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0500","first-page":"1029","article-title":"Influence of tramadol on neurotransmitter systems of the rat brain","volume":"46","author":"Frink","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/smrj.49_bb0505","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1743-6109.2006.00424.x","article-title":"Tramadol HCL has promise in on-demand use to treat premature ejaculation","volume":"5","author":"Salem","year":"2008","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0510","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.urology.2011.09.031","article-title":"On-demand tramadol hydrochloride use in premature ejaculation treatment","volume":"79","author":"Kaynar","year":"2011","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0515","first-page":"538","article-title":"[Safety and efficacy of tramadol hydrochloride with behavioral modification in the treatment of premature ejaculation]","volume":"17","author":"Xiong","year":"2011","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0520","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1111\/j.1743-6109.2010.01789.x","article-title":"Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation","volume":"7","author":"Alghobary","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0525","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2011.08.039","article-title":"A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes","volume":"61","author":"Bar-Or","year":"2011","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0530","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/aja.2012.96","article-title":"Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation","volume":"15","author":"Eassa","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1002\/smrj.49_bb0535","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1734-1140(12)70932-5","article-title":"Concomitant use of tramadol and venlafaxine\u2014evaluation of antidepressant-like activity and other behavioral effects in rats","volume":"64","author":"Szkutnik-Fiedler","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1002\/smrj.49_bb0540","first-page":"543","article-title":"Tramadol for osteoarthritis: A systematic review and metaanalysis","volume":"34","author":"Cepeda","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1002\/smrj.49_bb0545","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0310057X0403200417","article-title":"Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction","volume":"32","author":"Garrett","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"10.1002\/smrj.49_bb0550","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00002826-200405000-00012","article-title":"Serotonin syndrome associated with tramadol-sertraline coadministration","volume":"27","author":"Mittino","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1002\/smrj.49_bb0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/PCC.08l00690","article-title":"Serotonin syndrome associated with tramadol","volume":"11","author":"Takeshita","year":"2009","journal-title":"Prim Care Companion, J Clin Psychiary"},{"issue":"Suppl 2","key":"10.1002\/smrj.49_bb0560","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-199700532-00010","article-title":"[Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance]","volume":"53","author":"Cossmann","year":"1997","journal-title":"Drugs"},{"key":"10.1002\/smrj.49_bb0565","first-page":"72","article-title":"Clinical inquiries. What is the addiction risk associated with tramadol?","volume":"54","author":"McDiarmid","year":"2005","journal-title":"J Fam Pract"},{"key":"10.1002\/smrj.49_bb0570","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.10.006","article-title":"A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain","volume":"31","author":"Adams","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl 4","key":"10.1002\/smrj.49_bb0575","first-page":"S3","article-title":"The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia","volume":"8","author":"Lepor","year":"2006","journal-title":"Rev Urol"},{"key":"10.1002\/smrj.49_bb0580","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0090-4295(00)00744-5","article-title":"Alpha blockers: Are all created equal?","volume":"56","author":"Debruyne","year":"2000","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0585","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1464-410X.2004.05022.x","article-title":"Pharmacological therapy of benign prostatic hyperplasia\/lower urinary tract symptoms: An overview for the practising clinician","volume":"94","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0590","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1464-410X.1994.tb16546.x","article-title":"A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction","volume":"74","author":"Chapple","year":"1994","journal-title":"Br J Urol"},{"key":"10.1002\/smrj.49_bb0595","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0022-5347(17)36941-0","article-title":"A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia","volume":"148","author":"Lepor","year":"1992","journal-title":"J Urol"},{"key":"10.1002\/smrj.49_bb0600","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1994.tb17053.x","article-title":"Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery","volume":"113","author":"Hatano","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.49_bb0605","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjp.0707369","article-title":"Alpha1-adrenoceptors and ejaculatory function","volume":"152","author":"Michel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.49_bb0610","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/j.1743-6109.2008.00779.x","article-title":"Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers","volume":"5","author":"Kobayashi","year":"2008","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0615","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1442-2042.2006.01535.x","article-title":"Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission","volume":"13","author":"Hisasue","year":"2006","journal-title":"Int J Urol"},{"key":"10.1002\/smrj.49_bb0620","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000475036","article-title":"Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy","volume":"28","author":"Cavallini","year":"1995","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0625","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11255-005-3616-4","article-title":"Terazosin in the treatment of premature ejaculation: A short-term follow-up","volume":"37","author":"Basar","year":"2005","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.49_bb0630","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1442-2042.2011.02941.x","article-title":"Silodosin and its potential for treating premature ejaculation: A preliminary report","volume":"19","author":"Sato","year":"2012","journal-title":"Int J Urol"},{"key":"10.1002\/smrj.49_bb0635","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5534\/wjmh.2014.32.2.99","article-title":"Effects of tamsulosin on premature ejaculation in men with benign prostatic hyperplasia","volume":"32","author":"Choi","year":"2014","journal-title":"World J men's Health"},{"key":"10.1002\/smrj.49_bb0640","doi-asserted-by":"crossref","first-page":"e13805","DOI":"10.5812\/ircmj.13805","article-title":"Comparison of alpha blockers in treatment of premature ejaculation: A pilot clinical trial","volume":"15","author":"Akin","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"10.1002\/smrj.49_bb0645","series-title":"Hytrin (terazosin HCl tablets) [package insert]","first-page":"2008","year":"2006"},{"key":"10.1002\/smrj.49_bb0650","author":"Alfuzosin Prescribing Information","year":"2014"},{"key":"10.1002\/smrj.49_bb0655","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","article-title":"Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: Results of a phase III randomized, placebo-controlled, double-blind study in Japanese men","volume":"98","author":"Kawabe","year":"2006","journal-title":"BJU Int"},{"key":"10.1002\/smrj.49_bb0660","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/CIA.S13803","article-title":"Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia","volume":"6","author":"Yoshida","year":"2011","journal-title":"Clin Interv Aging"},{"key":"10.1002\/smrj.49_bb0665","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: Results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0670","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/pcan.2010.46","article-title":"Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH","volume":"14","author":"Roehrborn","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1002\/smrj.49_bb0675","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.urology.2010.03.015","article-title":"Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia","volume":"76","author":"Homma","year":"2010","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0680","first-page":"113","article-title":"Silodosin for the treatment of clinical benign prostatic hyperplasia: Safety, efficacy, and patient acceptability","volume":"6","author":"Cho","year":"2014","journal-title":"Res Rep Urol"},{"key":"10.1002\/smrj.49_bb0685","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ijir.2009.27","article-title":"Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration","volume":"21","author":"Kobayashi","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0690","first-page":"763","article-title":"[Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia; retrospective comparison between naftopidil and tamsulosin]","volume":"51","author":"Furuya","year":"2005","journal-title":"Hinyokika Kiyo"},{"key":"10.1002\/smrj.49_bb0695","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-4295(90)80149-H","article-title":"Intracavernous medication for treatment of premature ejaculation","volume":"35","author":"Fein","year":"1990","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0700","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1024569319319","article-title":"The relationships among ejaculatory control, ejaculatory latency, and attempts to prolong heterosexual intercourse","volume":"26","author":"Grenier","year":"1997","journal-title":"Arch Sex Behav"},{"key":"10.1002\/smrj.49_bb0705","first-page":"74","article-title":"Awareness of the role of the pelvic floor muscles in controlling the ejaculatory reflex: Preliminary results","volume":"84","author":"La Pera","year":"2012","journal-title":"Arch Ital Urol Androl"},{"key":"10.1002\/smrj.49_bb0710","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00926239608405302","article-title":"A new treatment for premature ejaculation: The rehabilitation of the pelvic floor","volume":"22","author":"La Pera","year":"1996","journal-title":"J Sex Marital Ther"},{"key":"10.1002\/smrj.49_bb0715","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4081\/aiua.2014.2.123","article-title":"Awareness and timing of pelvic floor muscle contraction, pelvic exercises and rehabilitation of pelvic floor in lifelong premature ejaculation: 5 years experience","volume":"86","author":"La Pera","year":"2014","journal-title":"Arch Ital Urol Androl"},{"key":"10.1002\/smrj.49_bb0720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1756287214523329","article-title":"Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: A novel therapeutic approach","volume":"6","author":"Pastore","year":"2014","journal-title":"Ther Adv Urol"},{"key":"10.1002\/smrj.49_bb0725","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2011.01243.x","article-title":"A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation","volume":"35","author":"Pastore","year":"2012","journal-title":"Int J Androl"},{"key":"10.1002\/smrj.49_bb0730","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.eururo.2011.01.019","article-title":"Acupuncture versus paroxetine for the treatment of premature ejaculation: A randomized, placebo-controlled clinical trial","volume":"59","author":"Sunay","year":"2011","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.49_bb0735","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ijir.3901226","article-title":"Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation","volume":"16","author":"Kim","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0740","first-page":"436","article-title":"[Selective resection of the branches of the two dorsal penile nerves for primary premature ejaculation]","volume":"14","author":"Shi","year":"2008","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1002\/smrj.49_bb0745","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ijir.2008.26","article-title":"Long-term effects of glans penis augmentation using injectable hyaluronic acid gel for premature ejaculation","volume":"20","author":"Kwak","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.49_bb0750","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2164\/jandrol.108.007344","article-title":"A novel treatment modality in patients with premature ejaculation resistant to conventional methods: The neuromodulation of dorsal penile nerves by pulsed radiofrequency","volume":"31","author":"Basal","year":"2010","journal-title":"J Androl"},{"key":"10.1002\/smrj.49_bb0755","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jvir.2012.09.015","article-title":"Percutaneous CT-guided cryoablation of the dorsal penile nerve for treatment of symptomatic premature ejaculation","volume":"24","author":"David Prologo","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1002\/smrj.49_bb0760","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.urology.2010.11.046","article-title":"Candidate molecule for premature ejaculation, DA-8031: In vivo and in vitro characterization of DA-8031","volume":"77","author":"Jeon","year":"2011","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0765","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/iju.12256","article-title":"Effect of DA-8031, a novel oral compound for premature ejaculation, on male rat sexual behavior","volume":"21","author":"Kang","year":"2014","journal-title":"Int J Urol"},{"key":"10.1002\/smrj.49_bb0770","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.urology.2012.12.006","article-title":"Ejaculatory responses are inhibited by a new chemical entity, DA-8031, in preclinical rodent models of ejaculation","volume":"81","author":"Kang","year":"2013","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0775","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urology.2014.03.014","article-title":"Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis","volume":"84","author":"Park","year":"2014","journal-title":"Urology"},{"key":"10.1002\/smrj.49_bb0780","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0149-7634(05)80176-9","article-title":"Oxytocin and sexual behavior","volume":"16","author":"Carter","year":"1992","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1002\/smrj.49_bb0785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1743-6109.2006.00394.x","article-title":"Oxytocin involvement in SSRI-induced delayed ejaculation: A review of animal studies","volume":"4","author":"de Jong","year":"2007","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0790","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/frne.1993.1009","article-title":"Central nervous system effects of the neurohypophyseal hormones and related peptides","volume":"14","author":"de Wied","year":"1993","journal-title":"Front Neuroendocrinol"},{"key":"10.1002\/smrj.49_bb0795","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cne.1137","article-title":"Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord","volume":"433","author":"Hallbeck","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1002\/smrj.49_bb0800","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-64-1-27","article-title":"Plasma oxytocin increases in the human sexual response","volume":"64","author":"Carmichael","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/smrj.49_bb0805","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00345-002-0300-5","article-title":"Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions","volume":"20","author":"Uckert","year":"2003","journal-title":"World J Urol"},{"key":"10.1002\/smrj.49_bb0810","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0361-9230(98)00180-4","article-title":"Excitation of oxytocin cells in the hypothalamic supraoptic nucleus by electrical stimulation of the dorsal penile nerve and tactile stimulation of the penis in the rat","volume":"48","author":"Honda","year":"1999","journal-title":"Brain Res Bull"},{"key":"10.1002\/smrj.49_bb0815","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0006-8993(96)00800-1","article-title":"Afferents originating from the dorsal penile nerve excite oxytocin cells in the hypothalamic paraventricular nucleus of the rat","volume":"733","author":"Yanagimoto","year":"1996","journal-title":"Brain Res"},{"key":"10.1002\/smrj.49_bb0820","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/joe.0.1070097","article-title":"Oxytocin and sexual behaviour in the male rat and rabbit","volume":"107","author":"Stoneham","year":"1985","journal-title":"J Endocrinol"},{"key":"10.1002\/smrj.49_bb0825","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0018-506X(85)90002-9","article-title":"Oxytocin improves male copulatory performance in rats","volume":"19","author":"Arletti","year":"1985","journal-title":"Horm Behav"},{"key":"10.1002\/smrj.49_bb0830","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(90)90178-9","article-title":"Sexual behavior of aging male rats is stimulated by oxytocin","volume":"179","author":"Arletti","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/smrj.49_bb0835","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1210\/en.2003-0962","article-title":"Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility","volume":"145","author":"Vignozzi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1002\/smrj.49_bb0840","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(02)00101-6","article-title":"Identification, localization and functional activity of oxytocin receptors in epididymis","volume":"193","author":"Filippi","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1002\/smrj.49_bb0845","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(83)90478-X","article-title":"Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF","volume":"262","author":"Mens","year":"1983","journal-title":"Brain Res"},{"key":"10.1002\/smrj.49_bb0850","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/bjp.2008.226","article-title":"Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V(1A) receptors and not oxytocin receptors","volume":"155","author":"Gupta","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.49_bb0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0091-3057(89)90433-4","article-title":"Apomorphine stimulation of male copulatory behavior is prevented by the oxytocin antagonist d(CH2)5 Tyr(Me)-Orn8-vasotocin in rats","volume":"33","author":"Argiolas","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/smrj.49_bb0860","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/bjp.2008.176","article-title":"Brain oxytocin receptors mediate ejaculation elicited by 7-hydroxy-2-(di-N-propylamino) tetralin (7-OH-DPAT) in anaesthetized rats","volume":"154","author":"Clement","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.49_bb0865","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/bph.12198","article-title":"Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: A multi-level site of action","volume":"169","author":"Clement","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1002\/smrj.49_bb0870","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2826.1994.tb00549.x","article-title":"Increased Fos expression in oxytocin neurons following masculine sexual behavior","volume":"6","author":"Witt","year":"1994","journal-title":"J Neuroendocrinol"},{"key":"10.1002\/smrj.49_bb0875","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.yhbeh.2010.12.012","article-title":"Oxytocin in the medial preoptic area facilitates male sexual behavior in the rat","volume":"59","author":"Gil","year":"2011","journal-title":"Horm Behav"},{"key":"10.1002\/smrj.49_bb0880","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/j.1460-9568.2009.06999.x","article-title":"Dopamine-oxytocin interactions in penile erection","volume":"30","author":"Baskerville","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1002\/smrj.49_bb0885","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/jsm.12272","article-title":"Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: A randomized, double-blind, placebo-controlled, fixed-dose study","volume":"10","author":"Shinghal","year":"2013","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0890","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: Potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/smrj.49_bb0895","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.1819-08.2008","article-title":"Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil","volume":"28","author":"Qu","year":"2008","journal-title":"J Neurosci"},{"key":"10.1002\/smrj.49_bb0900","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1743-6109.2009.01509.x","article-title":"The effects of oral administration of d-modafinil on male rat ejaculatory behavior","volume":"7","author":"Marson","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0905","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jnr.10196","article-title":"Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression","volume":"68","author":"Ferraro","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1002\/smrj.49_bb0910","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0028-3908(00)00019-8","article-title":"Amplification of cortical serotonin release: A further neurochemical action of the vigilance-promoting drug modafinil","volume":"39","author":"Ferraro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1002\/smrj.49_bb0915","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.physbeh.2004.08.018","article-title":"Dopamine and serotonin: Influences on male sexual behavior","volume":"83","author":"Hull","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1002\/smrj.49_bb0920","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.physbeh.2005.08.006","article-title":"Dopamine, the medial preoptic area, and male sexual behavior","volume":"86","author":"Dominguez","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1002\/smrj.49_bb0925","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/syn.20111","article-title":"Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat","volume":"55","author":"Ferraro","year":"2005","journal-title":"Synapse"},{"key":"10.1002\/smrj.49_bb0930","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-009-1493-8","article-title":"Depression-like deficits in rats improved by subchronic modafinil","volume":"204","author":"Regenthal","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/smrj.49_bb0935","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2006.09.005","article-title":"Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors","volume":"52","author":"Korotkova","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1002\/smrj.49_bb0940","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"key":"10.1002\/smrj.49_bb0945","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mehy.2009.07.038","article-title":"Botulinum toxin-A injection may be beneficial in the treatment of life-long premature ejaculation","volume":"74","author":"Serefoglu","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1002\/smrj.49_bb0950","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jsm.12553","article-title":"Effect of botulinum-A toxin injection into bulbospongiosus muscle on ejaculation latency in male rats","volume":"11","author":"Serefoglu","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.49_bb0955","series-title":"Method for treating premature ejaculation with a botulinum neurotoxin","author":"Gaxiola","year":"2012"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:24:25Z","timestamp":1748366665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052115301062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":190,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2050052115301062"],"URL":"https:\/\/doi.org\/10.1002\/smrj.49","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}